Cancer Family
Carcinoma
CI-CAN-00000114Explore in graph →
7,363 active trials118 approved drugs1,149 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000114Explore in graph →
Clinical trials
25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3,404)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00425204 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | completed | Phase 2 | 31 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00350961 | Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma | completed | Phase 1 / Phase 2 | 39 | Rigshospitalet, DenmarkOTHER | 1 | Aug 26, 2008 | clinicaltrials |
| NCT00251498 |
| Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer |
| completed |
| Phase 2 |
| 82 |
| Veeda OncologyOTHER |
| 1 |
| Aug 21, 2008 |
| clinicaltrials |
| NCT00129844 | Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | completed | Phase 2 | 108 | Pharmacyclics LLC.INDUSTRY | 2 | Aug 20, 2008 | clinicaltrials |
| NCT00154739 | Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 86 | National Taiwan University HospitalOTHER | 1 | Aug 4, 2008 | clinicaltrials |
| NCT00422786 | Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma | completed | Phase 2 | 10 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00050388 | Phase II Trial of Allovectin-7® for Head and Neck Cancer | completed | Phase 3 | — | VicalINDUSTRY | 1 | Jun 24, 2008 | clinicaltrials |
| NCT00196885 | Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training | completed | Phase 2 | 60 | German Cancer Research CenterOTHER | 1 | Jun 20, 2008 | clinicaltrials |
| NCT00698373 | Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study | completed | — | — | Gunma UniversityOTHER | 0 | Jun 17, 2008 | clinicaltrials |
| NCT00298688 | A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer | completed | Phase 2 | 56 | AstraZenecaINDUSTRY | 2 | Jun 12, 2008 | clinicaltrials |
| NCT00690703 | Radiofrequency Ablation of Pulmonary Tumors Response Evaluation(RAPTURE) | completed | Phase 2 | 106 | Angiodynamics, Inc.INDUSTRY | 5 | Jun 5, 2008 | clinicaltrials |
| NCT00139243 | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 0 | Jun 4, 2008 | clinicaltrials |
| NCT00139230 | Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00536861 | Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer | completed | Phase 1 | 11 | Amsterdam UMC, location VUmcOTHER | 1 | May 29, 2008 | clinicaltrials |
| NCT00217282 | Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 45 | Mt. Sinai Medical Center, MiamiOTHER | 1 | May 22, 2008 | clinicaltrials |
| NCT00679692 | Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease | completed | — | 210 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | May 19, 2008 | clinicaltrials |
| NCT00168987 | Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors | completed | Phase 4 | 30 | Charite University, Berlin, GermanyOTHER | 1 | May 9, 2008 | clinicaltrials |
| NCT00671242 | Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake(angiogenesis) | completed | — | — | Gunma UniversityOTHER | 1 | May 5, 2008 | clinicaltrials |
| NCT00250978 | Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 30, 2008 | clinicaltrials |
| NCT00327652 | Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases | completed | Phase 1 | 9 | Anza Therapeutics, Inc.INDUSTRY | 1 | Apr 24, 2008 | clinicaltrials |
| NCT00148395 | Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. | completed | Phase 3 | 280 | Aktion Bronchialkarzinom e.V.OTHER | 1 | Apr 22, 2008 | clinicaltrials |
| NCT00176137 | Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 500 | Heidelberg UniversityOTHER | 0 | Apr 22, 2008 | clinicaltrials |
| NCT00095186 | Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00635323 | Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma | completed | Phase 2 | 73 | PfizerINDUSTRY | 4 | Apr 7, 2008 | clinicaltrials |
| NCT00652587 | Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma | completed | Phase 3 | 115 | Sun Yat-sen UniversityOTHER | 1 | Apr 3, 2008 | clinicaltrials |
| NCT00139711 | Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer | completed | Phase 2 | 138 | PfizerINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00343720 | Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy | completed | Phase 2 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 13, 2008 | clinicaltrials |
| NCT00319514 | Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC | completed | Phase 2 | 78 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00059735 | A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma | completed | Phase 2 | 30 | Eisai Inc.INDUSTRY | 2 | Mar 5, 2008 | clinicaltrials |
| NCT00001339 | A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001381 | A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001383 | A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001442 | A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001450 | Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC | completed | Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001499 | Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001515 | Diagnostic Effectiveness of Virtual Bronchoscopy | completed | Phase 1 | 120 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001569 | Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | completed | Phase 1 | 74 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001603 | The Effects of Upper Airway and Digestive Tract Tumors on the Immune System | completed | — | 93 | National Institute on Deafness and Other Communication Disorders (NIDCD)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001683 | A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005660 | The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases | completed | — | 130 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00071344 | Analysis of Brain Metastasis in Patients With Lung Cancer | completed | — | 78 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00278070 | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors | completed | Phase 2 | — | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 29, 2008 | clinicaltrials |
| NCT00051974 | Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 155 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00051987 | Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma | completed | Phase 2 | 175 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00095225 | A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) | completed | Phase 2 | 122 | Genentech, Inc.INDUSTRY | 1 | Jan 29, 2008 | clinicaltrials |
| NCT00600522 | Alternative Surgical Policy for Central Liver Tumors | completed | — | 15 | University of MilanOTHER | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00080340 | Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 3 | 520 | TelikINDUSTRY | 8 | Jan 15, 2008 | clinicaltrials |
| NCT00082082 | A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma | completed | Phase 2 | — | SciClone PharmaceuticalsINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Sep 15, 2008source: clinicaltrials